{"id":297685,"date":"2023-12-29T08:28:10","date_gmt":"2023-12-29T15:28:10","guid":{"rendered":"https:\/\/dsiohn098w.mpqhf.org\/QIO\/?post_type=tribe_events&p=297685"},"modified":"2023-12-29T08:34:07","modified_gmt":"2023-12-29T15:34:07","slug":"ensuring-medication-for-opioid-use-disorder-moud-treatment-through-the-care-continuum-webinar-series-2","status":"publish","type":"tribe_events","link":"https:\/\/dsiohn098w.mpqhf.org\/QIO\/event\/ensuring-medication-for-opioid-use-disorder-moud-treatment-through-the-care-continuum-webinar-series-2\/","title":{"rendered":"Ensuring Medication for Opioid Use Disorder (MOUD) Treatment through the Care Continuum Webinar Series"},"content":{"rendered":"

This webinar series is a collaboration of all the Quality Innovation Network-Quality Improvement Organizations (QIN-QIOs) and will provide strategies, interventions and targeted solutions to ensure access to MOUD treatment and facilitate the continuity of care through the continuum.
\nPlease join us to hear from national experts during this monthly webinar series, September 2023 through June 2024.
\nSessions will take place on Fridays at
\n12 PM ET | 11 AM CT | 10 AM MT | 9 AM PT | 8 AM AKT.
\nRegister for this no-cost series: https:\/\/bit.ly\/MOUDthroughCareContinuumSeries
\nSession 1 \u2013 September 15, 2023:<\/strong>\u00a0Role of the Emergency Department (ED) Physician in the Treatment of Patients with OUD Basics and science of addiction and screening and initiating MOUD
\nSession 2 \u2013 October 13, 2023:<\/strong>\u00a0Role of the Pharmacist in the Treatment of Patients with OUD Medication processes, addressing opioid adverse drug events (ADEs) and risk assessment for opioid prescribing
\nSessions 3 (Part 1: Presentation) and 4 (Part 2: Panel Discussion) \u2013 November 17, 2023 and January 12, 2024:<\/strong>\u00a0Seamlessly Transitioning Patients on MOUD to Nursing Homes Discharge planning, medication reconciliation and readmission prevention
\nSessions 5 (Part 1: Presentation) and 6 (Part 2: Panel Discussion) \u2013 February 9, 2024 and March 8, 2024:<\/strong>\u00a0Management of Patients on MOUD During the Nursing Home Stay Admissions assessment and treatment, addressing stigma and naloxone training
\nSessions 7 (Part 1: Presentation) and 8 (Part 2: Panel Discussion) \u2013 April 12, 2024 and May 10, 2024:<\/strong>\u00a0Sustaining Recovery for Patients on MOUD Alternatives to Opioids (ALTO), peer support, narcotics anonymous meetings, counseling and use of technologies
\nSession 9 \u2013 June 7, 2024: Management of Patients on MOUD:<\/strong>\u00a0Key Takeaways and Series Wrap-up
\nA general certificate of attendance will be provided for continuing education\/contact hours. Attendees are responsible for determining if this program meets the criteria for licensure or recertification for their discipline.<\/p>\n

For questions about the series, contact:
\n<\/strong>Kyla Newland at\u00a0knewland@mpqhf.org<\/a>
\nLarissa Skinner at\u00a0lskinner@mpqhf.org<\/a><\/p>\n

QINQIOMOUDseriesFINAL<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

This webinar series is a collaboration of all the Quality Innovation Network-Quality Improvement Organizations (QIN-QIOs) and will provide strategies, interventions and targeted solutions to ensure access to MOUD treatment and facilitate the continuity of care through the continuum.
\nPlease join us to hear from national experts during this monthly webinar series, September 2023 through June 2024.
\nSessions will take place on Fridays at
\n12 PM ET | 11 AM CT | 10 AM MT | 9 AM PT | 8 AM AKT.
\nRegister for this no-cost series: https:\/\/bit.ly\/MOUDthroughCareContinuumSeries
\nSession 1 \u2013 September 15, 2023:\u00a0Role of the Emergency Department (ED) Physician in the Treatment of Patients with OUD Basics and science of addiction and screening and initiating MOUD
\nSession 2 \u2013 October 13, 2023:\u00a0Role of the Pharmacist in the Treatment of Patients with OUD Medication processes, addressing opioid adverse drug events (ADEs) and risk assessment for opioid prescribing
\nSessions 3 (Part 1: Presentation) and 4 (Part 2: Panel Discussion) \u2013 November 17, 2023 and January 12, 2024:\u00a0Seamlessly Transitioning Patients on MOUD to Nursing Homes Discharge planning, medication reconciliation and readmission prevention
\nSessions 5 (Part 1: Presentation) and 6 (Part 2: Panel Discussion) \u2013 February 9, 2024 and March 8, 2024:\u00a0Management of Patients on MOUD During the Nursing Home Stay Admissions assessment and treatment, addressing stigma and naloxone training
\nSessions 7 (Part 1: Presentation) and 8 (Part 2: Panel Discussion) \u2013 April 12, 2024 and May 10, 2024:\u00a0Sustaining Recovery for Patients on MOUD Alternatives to Opioids (ALTO), peer support, narcotics anonymous meetings, counseling and use of technologies
\nSession 9 \u2013 June 7, 2024: Management of Patients on MOUD:\u00a0Key Takeaways and Series Wrap-up
\nA general certificate of attendance will be provided for continuing education\/contact hours. Attendees are responsible for determining if this program meets the criteria for licensure or recertification for their discipline.
\nFor questions about the series, contact:
\nKyla Newland at\u00a0knewland@mpqhf.org<\/a>
\nLarissa Skinner at\u00a0lskinner@mpqhf.org<\/a>
\nQINQIOMOUDseriesFINAL<\/a><\/p>\n","protected":false},"author":17,"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","_tribe_events_status":"","_tribe_events_status_reason":"","_tribe_events_is_hybrid":"","_tribe_events_is_virtual":"","_tribe_events_virtual_video_source":"","_tribe_events_virtual_embed_video":"","_tribe_events_virtual_linked_button_text":"","_tribe_events_virtual_linked_button":"","_tribe_events_virtual_show_embed_at":"","_tribe_events_virtual_show_embed_to":[],"_tribe_events_virtual_show_on_event":"","_tribe_events_virtual_show_on_views":"","_tribe_events_virtual_url":"","footnotes":""},"tags":[],"tribe_events_cat":[1085],"class_list":["post-297685","tribe_events","type-tribe_events","status-publish","tribe_events_cat-webinar","cat_webinar","entry"],"_links":{"self":[{"href":"https:\/\/dsiohn098w.mpqhf.org\/QIO\/wp-json\/wp\/v2\/tribe_events\/297685"}],"collection":[{"href":"https:\/\/dsiohn098w.mpqhf.org\/QIO\/wp-json\/wp\/v2\/tribe_events"}],"about":[{"href":"https:\/\/dsiohn098w.mpqhf.org\/QIO\/wp-json\/wp\/v2\/types\/tribe_events"}],"author":[{"embeddable":true,"href":"https:\/\/dsiohn098w.mpqhf.org\/QIO\/wp-json\/wp\/v2\/users\/17"}],"replies":[{"embeddable":true,"href":"https:\/\/dsiohn098w.mpqhf.org\/QIO\/wp-json\/wp\/v2\/comments?post=297685"}],"version-history":[{"count":0,"href":"https:\/\/dsiohn098w.mpqhf.org\/QIO\/wp-json\/wp\/v2\/tribe_events\/297685\/revisions"}],"wp:attachment":[{"href":"https:\/\/dsiohn098w.mpqhf.org\/QIO\/wp-json\/wp\/v2\/media?parent=297685"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dsiohn098w.mpqhf.org\/QIO\/wp-json\/wp\/v2\/tags?post=297685"},{"taxonomy":"tribe_events_cat","embeddable":true,"href":"https:\/\/dsiohn098w.mpqhf.org\/QIO\/wp-json\/wp\/v2\/tribe_events_cat?post=297685"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}